Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

This study has been completed.
Sponsor:
Collaborator:
LG Life Sciences
Information provided by:
BioPartners GmbH
ClinicalTrials.gov Identifier:
NCT00600808
First received: July 23, 2007
Last updated: January 15, 2008
Last verified: July 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given